The role of coronary revascularization in the management of heart failure: Identification of candidates and review of results

Current Opinion in Cardiology

Volumn 11, Issue 3, 1996, Pages 276-290

  Blitz, Arie ^a   Laks, Hillel ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; MEDICAL LITERATURE; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; CORONARY DISEASE; ECHOCARDIOGRAPHY; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029889333     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199605000-00008     Document Type: Review

References (74)

1. Hosenpud J, Novick R, Breen T, Daily O: The registry of the International Society of Heart and Lung Transplantation: Eleventh Official Report-1994. J Heart Lung Transplant 1994, 13:561-570.
2. Rumberger J: Ventricular dilatation and remodeling after myocardial infarction. Mayo Clin Proc 1994, 69:664-674. Detailed review of the pathogenesis of left ventricular dysfunction following infarction.
3. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, et al.: Cellular mechanisms of myocardial infarct expansion. Circulation 1988, 78:186-201.
4. Schipke JD: Myocardial hibernation. Basic Res Cardiol 1995, 90:26-28.
5. Sheiban I, Tonni S, Marini A, Trevi G: Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. Am J Cardiol 1995, 75:23E-30E.
6. Ausma J, Cleutjens J, Thone F, Flameng W, et al: Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem 1995, 147:35-42.
7. Inglese E, Brambilla M, Dondi M, Pieri P, et al.: Assessment of myocardial viability after thallium-201 reinjection or rest-redistribution imaging: a multicenter study. The Italian Group of Nuclear Cardiology. J Nucl Med 1995, 36:555-563.
8. Dilsizian V, Perrone-Filardi P, Arrighi J, Bacharach S, et al.: Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Circulation 1993, 88:941-952.
9. Vanoverschelde JL, Gerber BL, AM DH, De Kock M, et al.: Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995, 92(suppl 9):II-37-II-44.
10. Galassi AR, Centamore G, Fiscella A, Coppola A, et al.: Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease. Am J Cardiol 1995, 75:436-442.
11. Udelson JE, Coleman PS, Metherall J, Pandian NG, et al.: Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201TI and 99mTc-sestamibi. Circulation 1994, 89:2552-2561.
12. Bisi G, Sciagra R, Santoro GM, Fazzini PF: Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994, 24:1282-1289.
13. Miron SD, Finkelhor R, Bahler R, Sodee DB, et al.: Use of Tc-99m sestamibi infusion for detection of hibernating myocardium: a preliminary report. Clin Nucl Med 1995, 20:440-445.
14. Worsley DF, Fung AY, Jue J, Burns RJ: Identification of viable myocardium with technetium-99m-MIBI Infusion. J Nucl Med 1995, 36:1037-1039.
15. Soufer R, Dey HM, Ng CK, Zaret BL: Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995, 75:1214-1219.
16. Grandin C, Wijns W, Melin JA, Bol A, et al.: Delineation of myocardial viability with PET. J Nucl Med 1995, 36:1543-1552.
17. Tamaki N, Kawamoto M, Tadamura E, Magata Y, et al.: Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995, 91:1697-1705.
18. Maddahi J, Blitz A, Phelps M, Laks H: The use of positron emission tomography imaging in the management of patients with ischemic cardiomyopathy. Advances Cardiac Surg 1996, 7:163-188. Detailed review of the role of PET in the selection of patients for revascularization and the results of clinical studies.
19. Marzullo P, Parodi O, Sambuceti G, Giorgetti A, et al.: Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities. J Am Coll Cardiol 1995, 26:342-350.
20. Senior R, Glenville B, Basu S, Sridhara BS, et al.: Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995, 74:358-364.
21. Haque T, Furukawa T, Takahashi M, Kinoshita M: Identification of hibernating myocardium by dobutamine stress echocardiography. comparison with thallium-201 reinjection imaging. Am Heart J 1995, 130(3 pt 1):553-563.
22. Mariani MA, Palagi C, Donatelli F, Mengozzi G, et al.: Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction. Am J Card Imaging 1995, 9:1-8.
23. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, et al.: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995, 91:2556-2565. Study revealing a strong correlation between improvement of ventricular function on DSE and improvement in contractile function after revascularization.
24. Watada H, Ito H, Oh H, Masuyama T, et al.: Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after rerperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994, 24:624-630.
25. Arnese M, Cornel JH, Salustri A, Maat A, et al.: Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201TI single-photon emission computed tomography. Circulation 1995, 91:2748-2752.
26. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, et al.: Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995, 91:990-998.
27. Meluzin J, Cigarroa CG, Brickner ME, Cerny J, et al.: Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol 1995, 76:877-880.
28. de Filippi CR, Willett DL, Irani WN, Eichhorn EJ, et al.: Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995, 92:2863-2868. Prospective study revealing equivalent predictive value of MCE and DSE for myocardial recovery following revascularization in hypokinetic segments but superior predictive value of DSE in akinetic segments.
29. Camarano G, Ragosta M, Gimple LW, Powers ER, et al.: Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. Am J Cardiol 1995, 75:215-219.
30. Jain D, Zaret BL: Nuclear imaging techniques for the assessment of myocardial viability. Cardiol Clin 1995, 13:43-57.
31. Hendel R, Chaudhry F, Bonow R: Myocardial viability. Curr Problems Cardiol 1996, 21:145-224. Extensive review of the methods of myocardial viability determination.
32. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, et al.: Myocardial viability in patients with chronic coronary artery disease: comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation 1994, 89:578-587. Prospective study demonstrating improved concordance of sestamibi imaging with either thallium redistribution/reinjection imaging or PET by considering the severity of reduction in sestamibi activity within irreversible defects and the addition of 4-hour redistribution images.
33. Tillisch J, Brunken R, Marshall R: Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med 1986, 314:884-888.
34. Tamaki N, Yonekura Y, Yamashita K: Positron emission tomography using fluorine-18-deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989, 64:860-865.
35. Tamaki N, Yonekura Y, Yamashita K, Magata Y, et al: Relation of change in wall motion and glucose metabolism after coronary artery bypass grafting: assessment with positron emission tomography. Jpn Circ J 1991, 55:923-929.
36. Gropler R, Siegel B, Sampathkumaran K: Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Cardiol 1992, 19:989-997.
37. Gropler R, Geltman E, Sampathkumaran K: Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993, 22:1587-1597.
38. Paolini G, Lucignani G, Zuccari M, Landoni C, et al.: Identification and revascularization of hibernating myocardium In angina-free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994, 8:139-144.
39. Carrel T, Jenni R, Haubold-Reuler S, Von-Schulthess G, et al.: Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 1992, 6:479-484.
40. Lucignani G, Paolini G, Landoni C, Zuccari M, et al.: Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992, 19:874-881.
41. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, et al.: Metabolic responses of hibernating and infarcted myocardium to revascularization: a follow-up of regional perfusion, function, and metabolism. Circulation 1992, 85:1347-1353.
42. Besozzi M, Brown M, Hubner K: Retrospective post therapy evaluation of cardiac function in 208 coronary artery disease patients evaluated by positron emission tomography [abstract]. J Nucl Med 1992, 33:885.
43. Depre C, Melin J, Vanoverschelde J: Assessment of myocardial viability after bypass surgery by pre-operative PET flow-metabolism measurements and ultrastructural analysis of myocardial biopsies [abstract]. Circulation 1993, 88(suppl 1):199.
44. Eitzman D, Al-Aouar Z, Kanter H: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Card 1992, 20:559-565.
45. Di Carli MF, Davidson M, Little R, Khanna S, et al.: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994, 73:527-533.
46. Di Carli MF, Asgarzadie F, Schelben HR, Brunken RC, et al.: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995, 92:3436-3444. Study revealing that the preoperative extent and magnitude of myocardial viability as determined by PET correlates with improvement in heart failure symptoms.
47. Louie HW, Laks H, Milgalter E, Drinkwater DC Jr, et al.: Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation 1991, 84(suppl 5):II-290-II-295.
48. Blitz A, Laks H, Drinkwater D, Scholl F, et al.: Revascularization versus transplantation for ischemic cardiomyopathy. Ann Thorac Surg 1996, in press.
49. Go RT, Maclntyre WJ, Saha GB, Cook SA, et al.: Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability. Radiology 1995, 194:151-155.
50. Tanimoto M, Pai RG, Jintapakorn W, Shah PM: Dobutamine stress echocardiography for the diagnosis and management of coronary artery disease. Clin Cardiol 1995, 18:252-260.
51. Christenson JT, Maurice J, Simonet F, Bloch A, et al.: Effect of low left ventricular ejection fractions on the outcome of primary coronary bypass grafting in end-stage coronary artery disease. J Cardiovasc Surg (Torino) 1995, 36:45-51.
52. Gill IS, Loop FD, Kramer J, Piedmonte M, et al.: Primary isolated coronary artery bypass in left ventricular dysfunction: survival and predictors of survival. Can J Cardiol 1994, 10:923-926.
53. Mickleborough L, Maruyama H, Takagi Y, Mohamed S, et al.: Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995, 92(suppl 2):II-73-II-79. Study demonstrating excellent clinical results in patients with ejection fractions of less than 20% undergoing revascularizations.
54. Langenburg SE, Buchanan SA, Blackbourne LH, Scheri RP, et al.: Predicting survival after coronary revascularization for Ischemic cardiomyopathy. Ann Thorac Surg 1995, 60:1193-1196; discussion 1196-1197.
55. Hausmann H, Ennker J, Topp H, Schuler S, et al.: Coronary artery bypass grafting and heart transplantation in end-stage coronary artery disease: a comparison of hemodynamic improvement and ventricular function. J Card Surg 1994, 9:77-84.
56. Alderman E, Fisher L, Litwin P, et al.: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983, 68:785-795.
57. Killip T, Passamani E, Davis K, C.p.i.a. Associates: A randomized trial of coronary bypass surgery: eight years follow-up and survival in patients with reduced ejection fraction. Circulation 1985, 72(suppl 5):V-102-V-109.
58. Pigott J, Kouchoukos N, Oberman A, Cutter G: Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985, 5:1036-1045.
59. Dreyfus G, Duboc D, Blasco A, Dubois C, et al.: Coronary surgery can be an alternative to heart transplantation in selected patients with end-stage ischemic heart disease. Eur J Cardiothorac Surg 1993, 7:482-487; discussion 488.
60. Eleftenades JA, Tous G Jr, Levi E, Mills LK, et al.: Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival improved ejection fraction and functional state. J Am Coll Cardiol 1993, 22:1411-1417.
61. Christakis G, Weisel R, Fremes S, Ivanov J, et al.: Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg 1992, 103:1083-1092.
62. Kron IL, Flanagan TL, Blackbourne LH, Schroeder RA, et al.: Coronary revascularization rather than cardiac transplantation for chronic Ischemic cardiomyopathy. Ann Surg 1989, 210:348-352; discussion 352-354.
63. Tyras DH, Kaiser GC, Barner HB, Pennington DG, et al.: Global left ventricular Impairment and myocardial revascularization: determinants of survival. Ann Thorac Surg 1984, 37:47-51.
64. Freeman WK, Schaff HV, PC OB, Orszulak TA, et al.: Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol 18:29-35.
65. Van Trigt P: Ischemic cardiomyopathy: the role of coronary artery bypass. Coron Artery Dis 1993, 49:707-712.
66. Milano CA, White WD, Smith LR, Jones RH, et al.: Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg 1993, 56:487-493.
67. Bounous E, Mark D, Pollock B, Hlatky M, et al.: Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988, 78(suppl 1):I-151-I-157.
68. Califf R, Harrell F, Lee K, Rankin J, et al.: The evolution of medical and surgical therapy for coronary artery disease: a 15-year experience. JAMA 1989, 261:2077-2086.
69. Jegaden O, de Gevigney G, Montagna P, Delahaye F, et al.: Late survival up to 20 years after isolated coronary by-pass surgery using internal mammary artery in patients with severe left ventricular dysfunction. J Cardiovasc Surg (Torino) 1994, 35:129-134.
70. Lansman SL, Cohen M, Galla JD, Machac J, et al.: Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long-term follow-up. Ann Thorac Surg 1993, 56:480-485; discussion 485-486.
71. Lucian GB, Faggian G, Razzolini R, Livi U, et al: Severe ischemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg 1993, 55:719-723.
72. Hamer AW, Takayama M, Abraham KA, Roche AH, et al.: End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation 1994, 90:2899-2904.
73. Ghods M, Pancholy S, Cave V, Cassell D, et al.: Serial changes in left ventricular function after bypass: implications in viability assessment. Am Heart J 1995, 129:20-23.
74. Yamaguchi A, Ino T, Adachi H, Mizuhara A, et al.: Left ventricular end-systolic volume Index in patients with ischemic cardiomyopathy predicts postoperative ventricular function. Ann Thorac Surg 1995, 60:1059-1062.